naltrexone has been researched along with Deficiency, Mental in 26 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 13 (50.00) | 18.2507 |
2000's | 6 (23.08) | 29.6817 |
2010's | 6 (23.08) | 24.3611 |
2020's | 1 (3.85) | 2.80 |
Authors | Studies |
---|---|
Hamzaoui, S; Kebir, O; Laqueille, X; Mouaffak, F | 1 |
Gormez, A; Rana, F; Varghese, S | 2 |
Findling, RL; Ji, NY | 1 |
Chicz-DeMet, A; Marion, SD; Sandman, CA; Touchette, PE | 1 |
Carminati, GG; Deriaz, N; Orihuela-Flores, M | 1 |
Borlongan, CV; Kaneko, Y; Su, TP; Tajiri, N; Wang, Y | 1 |
Banga, A; Connor, DF | 1 |
Rodriguez, MC; Symons, FJ; Thompson, A | 1 |
Buzan, RD; Dubovsky, SL; Thomas, M; Treadway, JT | 1 |
Buitelaar, JK; Nijhof, GJ; van England, H; Willemsen-Swinkels, SH | 1 |
Benjamin, S; Gagnon, M; Price, E; Seek, A; Tresise, L | 1 |
Aman, MG | 1 |
Axtell, S; Baker, D; Cerutti, D; Hackenberg, T; Thompson, T | 1 |
Casner, JA; Gualtieri, CT; Weinheimer, B | 1 |
Schultz, SK; White, T | 1 |
Chabane, N; Leboyer, M; Mouren-Simeoni, MC | 1 |
Bodfish, JW; Sutton, KA; Symons, FJ | 1 |
Bodfish, JW; Heeth, WL; Sutton, KA; Symons, FJ; Tapp, J; Wulfsberg, A | 1 |
Bouvard, M; Klingler, D; Lampl, C; Leboyer, M; Lensing, P; Panksepp, J; Plumet, MH | 1 |
Barron, JL; Hetrick, WP; Neri, CL; Sandman, CA; Taylor, DV; Touchette, P | 1 |
Lensing, P; Panksepp, J | 1 |
Broekema, W; Glaudemans-van Gelderen, I; Kars, H; van Ree, JM; Verhoeven, WM | 1 |
Barron, JL; Colman, H; Sandman, CA | 1 |
Barrett, RP; Feinstein, C; Hole, WT; Mercurio, A; Walters, AS | 1 |
Favazza, AR | 1 |
6 review(s) available for naltrexone and Deficiency, Mental
Article | Year |
---|---|
Pharmacological interventions for self-injurious behaviour in adults with intellectual disabilities.
Topics: Adult; Antidepressive Agents, Tricyclic; Clomipramine; Controlled Clinical Trials as Topic; Humans; Intellectual Disability; Naltrexone; Narcotic Antagonists; Self-Injurious Behavior | 2013 |
Pharmacological interventions for self-injurious behaviour in adults with intellectual disabilities: Abridged republication of a Cochrane systematic review.
Topics: Clomipramine; Humans; Intellectual Disability; Naltrexone; Narcotic Antagonists; Persons with Mental Disabilities; Risk Factors; Selective Serotonin Reuptake Inhibitors; Self-Injurious Behavior; Treatment Outcome | 2014 |
Pharmacotherapy for mental health problems in people with intellectual disability.
Topics: Aggression; Anticonvulsants; Antipsychotic Agents; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Cognition; Human Growth Hormone; Humans; Intellectual Disability; Lithium Compounds; Mental Disorders; Methylphenidate; Naltrexone; Narcotic Antagonists; Prader-Willi Syndrome; Psychotropic Drugs; Risperidone | 2016 |
Self-injurious behavior and the efficacy of naltrexone treatment: a quantitative synthesis.
Topics: Adolescent; Adult; Aged; Child; Clinical Trials as Topic; Dose-Response Relationship, Drug; Female; Humans; Intellectual Disability; Male; Middle Aged; Naltrexone; Self-Injurious Behavior; Sex Factors; Treatment Outcome | 2004 |
Efficacy of psychotropic drugs for reducing self-injurious behavior in the developmental disabilities.
Topics: Adrenergic beta-Antagonists; Anti-Anxiety Agents; Antidepressive Agents; Antipsychotic Agents; Female; Humans; Intellectual Disability; Lithium Carbonate; Male; Naloxone; Naltrexone; Receptors, Dopamine; Self-Injurious Behavior; Treatment Outcome | 1993 |
Opiate antagonists in children and adolescents.
Topics: Adolescent; Adolescent Psychiatry; Alcoholism; Autistic Disorder; Child; Feeding and Eating Disorders; Female; Humans; Intellectual Disability; Male; Naltrexone; Narcotic Antagonists | 2000 |
8 trial(s) available for naltrexone and Deficiency, Mental
Article | Year |
---|---|
The role of proopiomelanocortin (POMC) in sequentially dependent self-injurious behavior.
Topics: Adrenocorticotropic Hormone; Adult; Arousal; beta-Endorphin; Circadian Rhythm; Computers, Handheld; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Female; Follow-Up Studies; Humans; Intellectual Disability; Male; Middle Aged; Naltrexone; Narcotic Antagonists; Pro-Opiomelanocortin; Reference Values; Self-Injurious Behavior; Social Environment | 2008 |
Failure of naltrexone hydrochloride to reduce self-injurious and autistic behavior in mentally retarded adults. Double-blind placebo-controlled studies.
Topics: Adolescent; Adult; Autistic Disorder; Comorbidity; Cross-Over Studies; Double-Blind Method; Drug Administration Schedule; Female; Humans; Incidence; Intellectual Disability; Male; Middle Aged; Naltrexone; Placebos; Psychiatric Status Rating Scales; Self-Injurious Behavior; Stereotyped Behavior; Treatment Outcome | 1995 |
Opioid antagonist effects on self-injury in adults with mental retardation: response form and location as determinants of medication effects.
Topics: Adult; Clonidine; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Intellectual Disability; Liver Function Tests; Male; Naltrexone; Receptors, Opioid; Self-Injurious Behavior; Social Environment | 1994 |
Preliminary study of altered skin temperature at body sites associated with self-injurious behavior in adults who have developmental disabilities.
Topics: Adult; Arousal; Body Surface Area; Double-Blind Method; Female; Humans; Intellectual Disability; Male; Middle Aged; Naltrexone; Narcotic Antagonists; Self-Injurious Behavior; Skin Temperature | 2001 |
Sequential analysis of the effects of naltrexone on the environmental mediation of self-injurious behavior.
Topics: Adult; Environment; Humans; Intellectual Disability; Interpersonal Relations; Male; Middle Aged; Naltrexone; Narcotic Antagonists; Observer Variation; Self-Injurious Behavior; Stereotypic Movement Disorder | 2001 |
Naltrexone attenuates self-injurious behavior in mentally retarded subjects.
Topics: Administration, Oral; Adolescent; Adult; Brain; Clinical Trials as Topic; Double-Blind Method; Down Syndrome; Humans; Institutionalization; Intellectual Disability; Male; Naltrexone; Receptors, Opioid; Self Mutilation | 1990 |
An orally administered opiate blocker, naltrexone, attenuates self-injurious behavior.
Topics: Adult; Aggression; Dose-Response Relationship, Drug; Down Syndrome; Emotions; Humans; Intellectual Disability; Male; Motor Activity; Naltrexone; Receptors, Opioid; Self Mutilation; Stereotyped Behavior | 1990 |
A case report of naltrexone treatment of self-injury and social withdrawal in autism.
Topics: Adolescent; Autistic Disorder; Clinical Trials as Topic; Double-Blind Method; Humans; Intellectual Disability; Interpersonal Relations; Male; Naltrexone; Self Mutilation; Social Adjustment; Stereotyped Behavior | 1990 |
12 other study(ies) available for naltrexone and Deficiency, Mental
Article | Year |
---|---|
Kleptomania treated with naltrexone in a patient with intellectual disability
Topics: Adult; Disruptive, Impulse Control, and Conduct Disorders; Female; Humans; Intellectual Disability; Naltrexone; Narcotic Antagonists | 2020 |
Naltrexone in adults with intellectual disability improves compulsive and dissocial disorders: a case report.
Topics: Adult; Compulsive Behavior; Disruptive, Impulse Control, and Conduct Disorders; Female; Humans; Intellectual Disability; Naltrexone; Narcotic Antagonists; Treatment Outcome | 2010 |
Combination treatment of hypothermia and mesenchymal stromal cells amplifies neuroprotection in primary rat neurons exposed to hypoxic-ischemic-like injury in vitro: role of the opioid system.
Topics: Analgesics, Opioid; Animals; Cell Survival; Cell- and Tissue-Based Therapy; Glucose; HEK293 Cells; Humans; Hypothermia, Induced; Intellectual Disability; Lennox Gastaut Syndrome; Mesenchymal Stem Cells; Mitochondria; Naltrexone; Neurons; Neuroprotective Agents; Oxygen; Rats; Receptors, Opioid, delta; Reperfusion Injury; Spasms, Infantile | 2012 |
Effectiveness of naltrexone for treating pathologic skin picking behavior in an adolescent with Prader-Willi syndrome.
Topics: Adolescent; Antipsychotic Agents; Behavior Therapy; Compulsive Behavior; Humans; Intellectual Disability; Male; Naltrexone; Narcotic Antagonists; Prader-Willi Syndrome; Psychotic Disorders; Risperidone | 2012 |
Opiate antagonists for recurrent self-injurious behavior in three mentally retarded adults.
Topics: Adult; Behavior Therapy; Combined Modality Therapy; Down Syndrome; Drug Therapy, Combination; Female; Humans; Intellectual Disability; Naltrexone; Self-Injurious Behavior; Social Environment | 1995 |
Case study: paradoxical response to naltrexone treatment of self-injurious behavior.
Topics: Adult; Autistic Disorder; Dose-Response Relationship, Drug; Drug Administration Schedule; Humans; Intellectual Disability; Male; Naltrexone; Self-Injurious Behavior | 1995 |
Naltrexone and self-injurious behavior: a retrospective population study.
Topics: Adult; Female; Humans; Intellectual Disability; Male; Naltrexone; Narcotic Antagonists; Retrospective Studies; Self-Injurious Behavior | 1996 |
Naltrexone treatment for a 3-year-old boy with self-injurious behavior.
Topics: Child, Preschool; Developmental Disabilities; Follow-Up Studies; Humans; Intellectual Disability; Male; Naltrexone; Narcotic Antagonists; Self-Injurious Behavior; Treatment Outcome | 2000 |
Naltrexone open trial with a 5-year-old-boy. A social rebound reaction.
Topics: Attention Deficit Disorder with Hyperactivity; Autistic Disorder; Child, Preschool; Humans; Intellectual Disability; Male; Naltrexone; Personality Assessment; Social Behavior | 1992 |
Effect of naltrexone upon self-injurious behavior, learning and activity: a case study.
Topics: Adult; Autistic Disorder; Cognition; Humans; Hypnotics and Sedatives; Intellectual Disability; Learning; Male; Memory; Microcephaly; Motor Activity; Naltrexone; Self-Injurious Behavior | 1991 |
Brief report: a synopsis of an open-trial of naltrexone treatment of autism with four children.
Topics: Adolescent; Aggression; Attention; Autistic Disorder; Child; Child, Preschool; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Intellectual Disability; Male; Motor Activity; Naltrexone; Social Behavior; Social Environment | 1991 |
Treatment of patients with self-injurious behavior.
Topics: Fluphenazine; Humans; Intellectual Disability; Mental Disorders; Naltrexone; Self Mutilation | 1990 |